CLINICAL_TRIALS
trial_result
· 2025-03-30
Clinical Trial Update: AAVCAGsCD59 for the Treatment of Wet AMD [Phase 1]
Summary
Phase 1 clinical trial evaluating AAVCAGsCD59 for wet age-related macular degeneration has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Wet Age-related Macular Degeneration | Phase 1 | Status: COMPLETED